Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.60% is 69% below its 5-year average of 8.29%, near the low end of its 5-year range (2.60%–16.25%).
49.07% below its 12-month average of 5.11%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
2.60%
RETURN ON ASSETS (ROA) AVG TTM
5.11%
RETURN ON ASSETS (ROA) AVG 3Y
6.74%
RETURN ON ASSETS (ROA) AVG 5Y
8.29%
RETURN ON ASSETS (ROA) AVG 10Y
12.18%
RETURN ON ASSETS (ROA) AVG 15Y
13.12%
RETURN ON ASSETS (ROA) AVG 20Y
11.54%
CURRENT VS TTM AVG
-49.07%
CURRENT VS 3Y AVG
-61.41%
CURRENT VS 5Y AVG
-68.62%
CURRENT VS 10Y AVG
-78.65%
CURRENT VS 15Y AVG
-80.18%
CURRENT VS 20Y AVG
-77.47%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-49.42%
vs the sector median at left
Biogen Inc.
Market Cap
$31.40B
Return on Assets (ROA)
2.60%
TTM Avg
5.11%
3Y Avg
6.74%
5Y Avg
8.29%
Market Cap
$31.63B
Return on Assets (ROA)
-6.14%
TTM Avg
-2.29%
3Y Avg
0.04%
5Y Avg
0.75%
Market Cap
$30.85B
Return on Assets (ROA)
17.35%
TTM Avg
17.37%
3Y Avg
16.33%
5Y Avg
15.33%
Market Cap
$31.95B
Return on Assets (ROA)
16.99%
TTM Avg
17.06%
3Y Avg
15.57%
5Y Avg
14.60%
Market Cap
$31.88B
Return on Assets (ROA)
15.49%
TTM Avg
11.04%
3Y Avg
9.26%
5Y Avg
8.83%
Market Cap
$30.63B
Return on Assets (ROA)
0.67%
TTM Avg
13.34%
3Y Avg
15.53%
5Y Avg
17.15%
Market Cap
$30.05B
Return on Assets (ROA)
4.27%
TTM Avg
5.83%
3Y Avg
5.87%
5Y Avg
14.86%
Market Cap
$29.30B
Return on Assets (ROA)
1.76%
TTM Avg
3.17%
3Y Avg
1.75%
5Y Avg
1.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biogen Inc. (BIIB) | $31.40B | 2.60% | 5.11% | 6.74% | 8.29% |
| Centene Corp. (CNC)vs › | $31.63B | -6.14% | -2.29% | 0.04% | 0.75% |
| Zoetis Inc. (ZTS)vs › | $30.85B | 17.35% | 17.37% | 16.33% | 15.33% |
| ResMed Inc. (RMD)vs › | $31.95B | 16.99% | 17.06% | 15.57% | 14.60% |
| DexCom, Inc. (DXCM)vs › | $31.88B | 15.49% | 11.04% | 9.26% | 8.83% |
| Waters Corporation (WAT)vs › | $30.63B | 0.67% | 13.34% | 15.53% | 17.15% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.05B | 4.27% | 5.83% | 5.87% | 14.86% |
| Medline Inc. (MDLN)vs › | $29.30B | 1.76% | 3.17% | 1.75% | 1.75% |
| Alcon Inc. (ALC)vs › | $33.61B | 2.06% | 3.23% | 2.72% | 1.72% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.27B | 14.54% | -0.12% | -10.91% | -15.37% |
ROA
2.6%
ROE
4.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.39% |
| 2024-12-31 | 5.82% |
| 2023-12-31 | 4.33% |
| 2022-12-31 | 12.41% |
| 2021-12-31 | 6.52% |
| 2020-12-31 | 16.25% |
| 2019-12-31 | 21.62% |
| 2018-12-31 | 17.52% |
| 2017-12-31 | 10.73% |
| 2016-12-31 | 16.19% |
| 2015-12-31 | 18.19% |
| 2014-12-31 | 20.50% |
| 2013-12-31 | 15.70% |
| 2012-12-31 | 13.62% |
| 2011-12-31 | 13.64% |
| 2010-12-31 | 12.42% |
| 2009-12-31 | 11.34% |
| 2008-12-31 | 9.24% |
| 2007-12-31 | 7.40% |
| 2006-12-31 | 2.54% |
| 2005-12-31 | 1.92% |
| 2004-12-31 | 0.27% |
| 2003-12-31 | -9.21% |
| 2002-12-31 | 7.38% |
| 2001-12-31 | 15.84% |
| 2000-12-31 | 23.30% |
| 1999-12-31 | 17.25% |
| 1998-12-31 | 15.00% |
| 1997-12-31 | 10.96% |
| 1996-12-31 | 6.39% |
